ACUR

Acura Pharmaceuticals, Inc. ACUR

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ACUR PTLF NUGS ARYX INSO VFRM BHNGF AOLS NNRX HCANF
6M -97.98 % 0.00 % 0.00 % 0.00 % 0.00 % -50.00 % 0.00 % 0.00 % 4 900.00 % 0.00 %
YTD 100.00 % 0.00 % 9 900.00 % 0.00 % 0.00 % -87.50 % 0.00 % -66.67 % -50.00 % 0.00 %
1Y -63.67 % 0.00 % 9 900.00 % 0.00 % -95.00 % -95.00 % 0.00 % 0.00 % -50.00 % 0.00 %
3Y -92.00 % -95.00 % -98.46 % 0.00 % -99.50 % -99.41 % -99.47 % 0.00 % -75.00 % -99.89 %
5Y -99.83 % 5.26 % -99.84 % -86.11 % -99.77 % -99.97 % -99.80 % -93.75 % -50.00 % -100.00 %
10Y -99.99 % -98.00 % -99.85 % -84.85 % -100.00 % -99.99 % -99.67 % -99.96 % -93.75 % -100.00 %
From the beginning -100.00 % -100.00 % -99.92 % -99.99 % -100.00 % -99.99 % -99.99 % -100.00 % -99.96 % -100.00 %

Dividend